79745-6
International classification of retinoblastoma Intraocular retinoblastoma classification at final disease stage Right eye
Active
Term Description
This term was developed in collaboration with the National Institute of Health's National Eye Institute (NEI) as part of an effort to standardize the data elements collected by the National Ophthalmic Disease Genotyping and Phenotyping Network (eyeGENE).
Source: Regenstrief LOINC
Part Descriptions
LP201234-4 Intraocular retinoblastoma classification
The International Classification for Intraocular Retinoblastoma (ICRB) is the newer retinoblastoma staging system, which takes into account what has been learned about the disease in recent decades. Due to early diagnosis, extraocular spread of retinoblastoma has become less common, however, for cases with extraocular involvement, the most commonly used staging system is the Reese-Ellsworth staging system.
The ICRB divides intraocular retinoblastomas into 5 groups, labeled A through E, based on the chances that the eye can be saved using current treatment options.
Group A - Small tumors (3 mm across or less) that are only in the retina and are not near important structures such as the optic disc (where the optic nerve enters the retina) or the foveola (the center of vision).
Group B - All other tumors (either larger than 3 mm or small but close to the optic disc or foveola) that are confined to the retina.
Group C - Well-defined tumors with small amounts of spread under the retina (subretinal seeding) or into the jelly-like material that fills the eye (vitreous seeding).
Group D - Large or poorly defined tumors with widespread vitreous or subretinal seeding. The retina may have become detached from the back of the eye.
Group E - The tumor is very large, extends near the front of the eye, is bleeding or causing glaucoma (high pressure inside the eye), or has other features that mean there is almost no chance the eye can be saved.
[http://www.cancer.org/cancer/retinoblastoma/detailedguide/retinoblastoma-staging]
Source: Regenstrief LOINC,
LP203649-1 EYE.HX.NEI
Developed in collaboration with the National Institute of Health's National Eye Institute (NEI) as part of an effort to standardize the data elements collected by the National Ophthalmic Disease Genotyping and Phenotyping Network (eyeGENE).
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Intraocular retinoblastoma classification^at final disease stage
- Property
- Class
- Time
- Pt
- System
- Eye.right
- Scale
- Ord
- Method
- ICRB
Additional Names
- Short Name
- ICRB class final dis stage Eye-R
Normative Answer List: LL3732-6
Source: National Eye InstituteAnswer | Code | Score | Answer ID |
---|---|---|---|
No tumor | 0 | LA24815-5 | |
Group ACopyright http://snomed.info/sct ID:112144000 Blood group A (finding) | 1 | LA19710-5 | |
Group BCopyright http://snomed.info/sct ID:112149005 Blood group B (finding) | 2 | LA19709-7 | |
Group C | 3 | LA24737-1 | |
Group D | 4 | LA24738-9 | |
Group E | 5 | LA24739-7 | |
UnknownCopyright http://snomed.info/sct ID:261665006 Unknown (qualifier value) | UNK | LA4489-6 |
Basic Attributes
- Class
- EYE.HX.NEI
- Type
- Clinical
- First Released
- Version 2.54
- Last Updated
- Version 2.54
- Order vs. Observation
- Observation
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Clasificación del retinoblastoma intraocular ^ en la etapa final de la enfermedad: |
it-IT | Italian (Italy) | Classificazione del retinoblastoma intraoculare^allo stadio finale di malattia: Synonyms: Concetti storia NEI eyeGENE Fase Occhio Occhio Destro Punto nel tempo (episodio) Stadio della malattia |
zh-CN | Chinese (China) | 眼内视网膜母细胞瘤分类^最终疾病分期时: Synonyms: R RT 依次型; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=79745-6
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright